BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 11438451)

  • 21. DCC genetic alterations and expression in endometrial carcinoma.
    Ronnett BM; Burks RT; Cho KR; Hedrick L
    Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered expression and loss of heterozygosity of the LOT1 gene in ovarian cancer.
    Cvetkovic D; Pisarcik D; Lee C; Hamilton TC; Abdollahi A
    Gynecol Oncol; 2004 Dec; 95(3):449-55. PubMed ID: 15581945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of chromosome 18q and DPC4 (Smad4) mutations in appendiceal adenocarcinomas.
    Maru D; Wu TT; Canada A; Houlihan PS; Hamilton SR; Rashid A
    Oncogene; 2004 Jan; 23(3):859-64. PubMed ID: 14647445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts.
    Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH
    Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of serous and mucinous ovarian carcinomas: distinct pattern of allelic loss at distal 8p and expression of transcription factor GATA-4.
    Lassus H; Laitinen MP; Anttonen M; Heikinheimo M; Aaltonen LA; Ritvos O; Butzow R
    Lab Invest; 2001 Apr; 81(4):517-26. PubMed ID: 11304571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SMAD4 as a prognostic marker in colorectal cancer.
    Alazzouzi H; Alhopuro P; Salovaara R; Sammalkorpi H; Järvinen H; Mecklin JP; Hemminki A; Schwartz S; Aaltonen LA; Arango D
    Clin Cancer Res; 2005 Apr; 11(7):2606-11. PubMed ID: 15814640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of human meningiomas for aberrations of the MADH2, MADH4, APM-1 and DCC tumor suppressor genes on the long arm of chromosome 18.
    Büschges R; Boström J; Wolter M; Blaschke B; Weber RG; Lichter P; Collins VP; Reifenberger G
    Int J Cancer; 2001 May; 92(4):551-4. PubMed ID: 11304690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No SMAD4 hypermethylation in colorectal cancer.
    Roth S; Laiho P; Salovaara R; Launonen V; Aaltonen LA
    Br J Cancer; 2000 Oct; 83(8):1015-9. PubMed ID: 10993648
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas.
    MacGrogan D; Pegram M; Slamon D; Bookstein R
    Oncogene; 1997 Aug; 15(9):1111-4. PubMed ID: 9285566
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ITF-2 is disrupted via allelic loss of chromosome 18q21, and ITF-2B expression is lost at the adenoma-carcinoma transition.
    Herbst A; Bommer GT; Kriegl L; Jung A; Behrens A; Csanadi E; Gerhard M; Bolz C; Riesenberg R; Zimmermann W; Dietmaier W; Wolf I; Brabletz T; Göke B; Kolligs FT
    Gastroenterology; 2009 Aug; 137(2):639-48, 648.e1-9. PubMed ID: 19394332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human gastric adenocarcinoma allelotype on chromosomes 17 and 18.
    Yu JC; Zhou H; Bai J; Yu Y; Geng JS; Qi JP; Fu SB
    J Int Med Res; 2008; 36(2):279-88. PubMed ID: 18380938
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DPC4 gene in various tumor types.
    Schutte M; Hruban RH; Hedrick L; Cho KR; Nadasdy GM; Weinstein CL; Bova GS; Isaacs WB; Cairns P; Nawroz H; Sidransky D; Casero RA; Meltzer PS; Hahn SA; Kern SE
    Cancer Res; 1996 Jun; 56(11):2527-30. PubMed ID: 8653691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion mapping of 18q in conventional renal cell carcinoma.
    Hirata H; Matsuyama H; Matsumoto H; Korenaga Y; Ohmi C; Sakano S; Yoshihiro S; Naito K
    Cancer Genet Cytogenet; 2005 Dec; 163(2):101-5. PubMed ID: 16337851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Deletion mapping of chromosome 18q and Smad proteins expression analysis in urinary bladder carcinomas].
    Fan Z; Zhang J; Bai J
    Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):135-7. PubMed ID: 11783019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of DCC gene expression during ovarian tumorigenesis: relation to tumour differentiation and progression.
    Saegusa M; Machida D; Okayasu I
    Br J Cancer; 2000 Feb; 82(3):571-8. PubMed ID: 10682668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients.
    Koyama M; Ito M; Nagai H; Emi M; Moriyama Y
    Mutat Res; 1999 Aug; 406(2-4):71-7. PubMed ID: 10479724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetics of adenocarcinomas of the small intestine: frequent deletions at chromosome 18q and mutations of the SMAD4 gene.
    Bläker H; von Herbay A; Penzel R; Gross S; Otto HF
    Oncogene; 2002 Jan; 21(1):158-64. PubMed ID: 11791187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus.
    Chenevix-Trench G; Leary J; Kerr J; Michel J; Kefford R; Hurst T; Parsons PG; Friedlander M; Khoo SK
    Oncogene; 1992 Jun; 7(6):1059-65. PubMed ID: 1594239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular analyses of the 15q and 18q SMAD genes in pancreatic cancer.
    Jonson T; Gorunova L; Dawiskiba S; Andrén-Sandberg A; Stenman G; ten Dijke P; Johansson B; Höglund M
    Genes Chromosomes Cancer; 1999 Jan; 24(1):62-71. PubMed ID: 9892110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.